Prof B Smit informed the Committee that clear benefits are emerging from government implementation of the government HIV and AIDS treatment plan. He argues that SA loses 0,5% growth per year, and although this is not likely to have an impact on growth going forward, it gains 0,1% of growth since the provision of the antiretroviral (ARV) drugs to sufferers. The cost of between 15% - 20% is recouped.